Ozempic 0.25 mg / 0.5 mg Pen
  1. Home
  2. Ozempic
  3. Ozempic 0.25 mg / 0.5 mg Pen

Ozempic 0.25 mg / 0.5 mg Pen

Ozempic 0.25 mg / 0.5 mg Pen is a prescription GLP-1 receptor agonist supplied in a prefilled, multi-dose injection pen for improving glycemic control in adults with type 2 diabetes. It delivers adjustable 0.25 mg and 0.5 mg subcutaneous doses through an easy-to-use pen designed for once-weekly administration. The ergonomic prefilled pen enhances convenience and supports long-term treatment adherence.

BUY NOW

Category

Ozempic 0.25 mg / 0.5 mg Pen contains semaglutide, a long-acting GLP-1 receptor agonist that helps improve blood glucose control by stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. The multi-dose prefilled pen is engineered to deliver both the initial 0.25 mg dose and the maintenance 0.5 mg dose with precise once-weekly administration, making routine diabetes management more convenient. Manufactured under stringent pharmaceutical quality standards, each pen is supplied sterile for single-patient use. Ozempic should be administered only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Ozempic 0.25 mg / 0.5 mg Pen
Active Ingredient Semaglutide
Strength 0.25 mg / 0.5 mg
Dosage Form Prefilled Multi-Dose Injection Pen
Route of Administration Subcutaneous Injection
Storage Refrigerated at 2°C–8°C before first use

Product Also Known As

Ozempic 0.25 mg / 0.5 mg Pen, Ozempic Starter Pen, Semaglutide 0.25 mg Pen, Semaglutide 0.5 mg Pen, GLP-1 Injection Pen, Ozempic Multi-Dose Pen, Weekly Semaglutide Pen.